NCI Licenses Agilent's Bioinformatics Platforms | GenomeWeb
NEW YORK (GenomeWeb News) — The National Cancer Institute has purchased a full site license to Agilent Technologies’ bioinformatics products, Agilent announced today.
 
The NCI will use Agilent's GeneSpring, CGH Analytics, Agilent Chip Analytics, and GeneSpring GT platforms for research and analysis.
 
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.